Tag: COVID-19
29
Mar
Managing Anticoagulant Risks During Respiratory Infections and COVID-19
Explore how respiratory infections disrupt blood thinner metabolism. Learn about drug interactions with CYP3A4, specific risks with DOACs vs Warfarin, and current clinical management strategies.
READ MORE© 2026. All rights reserved.